These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29556627)

  • 21. Prospective evaluation of pulmonary edema.
    Edoute Y; Roguin A; Behar D; Reisner SA
    Crit Care Med; 2000 Feb; 28(2):330-5. PubMed ID: 10708162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
    Zile MR; Claggett BL; Prescott MF; McMurray JJ; Packer M; Rouleau JL; Swedberg K; Desai AS; Gong J; Shi VC; Solomon SD
    J Am Coll Cardiol; 2016 Dec; 68(22):2425-2436. PubMed ID: 27908347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry.
    Targher G; Dauriz M; Tavazzi L; Temporelli PL; Lucci D; Urso R; Lecchi G; Bellanti G; Merlo M; Rossi A; Maggioni AP;
    Int J Cardiol; 2016 Jan; 203():587-93. PubMed ID: 26574932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between cardiac, renal, and hepatic biomarkers and outcomes in patients with acute heart failure.
    Chan WW; Waltman Johnson K; Friedman HS; Navaratnam P
    Hosp Pract (1995); 2016 Aug; 44(3):138-45. PubMed ID: 27292609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
    Greene SJ; Maggioni AP; Fonarow GC; Solomon SD; Böhm M; Kandra A; Prescott MF; Reimund B; Hua TA; Lesogor A; Zannad F; Gheorghiade M;
    Eur J Heart Fail; 2015 Jan; 17(1):98-108. PubMed ID: 25597870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.
    Pimenta JM; Almeida R; Araújo JP; Azevedo A; Friões F; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    J Card Fail; 2007 May; 13(4):275-80. PubMed ID: 17517347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
    Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical presentation and pharmacological therapy in patients with cardiogenic pulmonary oedema.
    Fiutowski M; Waszyrowski T; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2004 Dec; 61(12):561-9; discussion 570. PubMed ID: 15815756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of discharge haemoglobin and NT-proBNP to improve short and long-term outcome prediction in patients with acute heart failure.
    Stojcevski B; Celic V; Navarin S; Pencic B; Majstorovic A; Sljivic A; Magrini L; Cristofano F; Cavalieri L; Di Somma S;
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):676-684. PubMed ID: 25943556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol PE; Schroeder-Tanka JM; Voogel AJ; Keijer JT; Kortz RA; Dickhoff C; Meregalli PG; Tijssen JG; Pinto YM; Kok WE
    Am Heart J; 2014 Jul; 168(1):30-6. PubMed ID: 24952857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
    Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study.
    Cleland JG; Chiswell K; Teerlink JR; Stevens S; Fiuzat M; Givertz MM; Davison BA; Mansoor GA; Ponikowski P; Voors AA; Cotter G; Metra M; Massie BM; O'Connor CM
    Circ Heart Fail; 2014 Jan; 7(1):76-87. PubMed ID: 24281134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-hospital worsening heart failure in patients admitted for acute heart failure.
    Carubelli V; Cotter G; Davison B; Gishe J; Senger S; Bonadei I; Gorga E; Lazzarini V; Lombardi C; Metra M
    Int J Cardiol; 2016 Dec; 225():353-361. PubMed ID: 27756041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
    Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
    JACC Heart Fail; 2016 Sep; 4(9):736-45. PubMed ID: 27395353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiogenic pulmonary oedema: alarmingly poor long term prognosis. Analysis of risk factors.
    Marcinkiewicz M; Ponikwicka K; Szpakowicz A; Musiał WJ; Kamiński KA
    Kardiol Pol; 2013; 71(7):712-20. PubMed ID: 23907904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
    Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].
    Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA
    Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study.
    Sanchez O; Trinquart L; Caille V; Couturaud F; Pacouret G; Meneveau N; Verschuren F; Roy PM; Parent F; Righini M; Perrier A; Lorut C; Tardy B; Benoit MO; Chatellier G; Meyer G
    Am J Respir Crit Care Med; 2010 Jan; 181(2):168-73. PubMed ID: 19910608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.